{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:50Z","timestamp":1793851490006,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH188"],"award-info":[{"award-number":["ZR2021MH188"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300383"],"award-info":[{"award-number":["81300383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900121"],"award-info":[{"award-number":["81900121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973994"],"award-info":[{"award-number":["81973994"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070122"],"award-info":[{"award-number":["82070122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholars Program","award":["tsqn202103167"],"award-info":[{"award-number":["tsqn202103167"]}]},{"name":"Clinical Research Project of Shandong University","award":["2020SDUCRCC015"],"award-info":[{"award-number":["2020SDUCRCC015"]}]},{"name":"Young Taishan Scholar Foundation of Shandong Province","award":["tsqn201909175"],"award-info":[{"award-number":["tsqn201909175"]}]},{"name":"Natural Science Foundation for Distinguished Young Scholar of Shandong Province","award":["ZR2021JQ28"],"award-info":[{"award-number":["ZR2021JQ28"]}]},{"name":"Clinical Research Center of Shandong University","award":["2020SDUCRCC009"],"award-info":[{"award-number":["2020SDUCRCC009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00277-023-05348-6","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T06:01:37Z","timestamp":1688796097000},"page":"2317-2327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia"],"prefix":"10.1007","volume":"102","author":[{"given":"Yujiao","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"5348_CR1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","volume":"9","author":"M Swinkels","year":"2018","unstructured":"Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FWG, Jansen AJG (2018) Emerging concepts in immune thrombocytopenia. Front Immunol 9:880. https:\/\/doi.org\/10.3389\/fimmu.2018.00880","journal-title":"Front Immunol"},{"issue":"5","key":"5348_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-0609.1995.tb00702.x","volume":"55","author":"M Hou","year":"1995","unstructured":"Hou M, Stockelberg D, Kutti J, Wadenvik H (1995) Antibodies against platelet Gpib\/Ix, Gpiib\/Iiia, and other platelet antigens in chronic idiopathic thrombocytopenic purpura. Eur J Haematol 55(5):307\u2013314","journal-title":"Eur J Haematol"},{"issue":"18","key":"5348_CR3","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1182\/blood-2014-03-563445","volume":"124","author":"S Audia","year":"2014","unstructured":"Audia S, Rossato M, Santegoets K et al (2014) Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia. Blood 124(18):2858\u20132866. https:\/\/doi.org\/10.1182\/blood-2014-03-563445","journal-title":"Blood"},{"issue":"9","key":"5348_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/nm921","volume":"9","author":"B Olsson","year":"2003","unstructured":"Olsson B, Andersson PO, Jernas M et al (2003) T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 9(9):1123\u20131124. https:\/\/doi.org\/10.1038\/nm921","journal-title":"Nat Med"},{"key":"5348_CR5","doi-asserted-by":"publisher","unstructured":"Zufferey A, Kapur R, Semple JW (2017) Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med 6(2). https:\/\/doi.org\/10.3390\/jcm6020016","DOI":"10.3390\/jcm6020016"},{"issue":"11","key":"5348_CR6","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00277-016-2703-1","volume":"95","author":"E Khodadi","year":"2016","unstructured":"Khodadi E, Asnafi AA, Shahrabi S, Shahjahani M, Saki N (2016) Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis. Ann Hematol 95(11):1765\u20131776. https:\/\/doi.org\/10.1007\/s00277-016-2703-1","journal-title":"Ann Hematol"},{"issue":"10","key":"5348_CR7","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1182\/blood-2013-05-502807","volume":"122","author":"M Jernas","year":"2013","unstructured":"Jernas M, Hou Y, Celind FS et al (2013) Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP. Blood 122(10):1789\u20131792. https:\/\/doi.org\/10.1182\/blood-2013-05-502807","journal-title":"Blood"},{"key":"5348_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.molimm.2017.11.010","volume":"93","author":"S Wang","year":"2018","unstructured":"Wang S, Guan Y, Wang Y et al (2018) Reduced PTEN involved in primary immune thrombocytopenia via contributing to B cell hyper-responsiveness. Mol Immunol 93:144\u2013151. https:\/\/doi.org\/10.1016\/j.molimm.2017.11.010","journal-title":"Mol Immunol"},{"key":"5348_CR9","doi-asserted-by":"publisher","unstructured":"Hayashi T, Nakamae H, Takeda S, et al. Increasing numbers of CD19 + CD24(high)CD38(high) regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune thrombocytopenia. Int J Hematol 2021;114(5):580-90 doi: https:\/\/doi.org\/10.1007\/s12185-021-03192-w.","DOI":"10.1007\/s12185-021-03192-w"},{"issue":"1","key":"5348_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/JCI113060","volume":"80","author":"PJ Ballem","year":"1987","unstructured":"Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ (1987) Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 80(1):33\u201340. https:\/\/doi.org\/10.1172\/JCI113060","journal-title":"J Clin Invest"},{"issue":"3","key":"5348_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5482\/HAMO-14-09-0043","volume":"36","author":"T Bakchoul","year":"2016","unstructured":"Bakchoul T, Sachs UJ (2016) Platelet destruction in immune thrombocytopenia. Understanding the mechanisms. Hamostaseologie 36(3):187\u2013194. https:\/\/doi.org\/10.5482\/HAMO-14-09-0043","journal-title":"Hamostaseologie"},{"issue":"20","key":"5348_CR12","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1182\/bloodadvances.2020003860","volume":"5","author":"TS Yu","year":"2021","unstructured":"Yu TS, Wang HY, Zhao YJ et al (2021) Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia. Blood Adv 5(20):4087\u20134101. https:\/\/doi.org\/10.1182\/bloodadvances.2020003860","journal-title":"Blood Adv"},{"issue":"1","key":"5348_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1172\/JCI65689","volume":"123","author":"M Mahevas","year":"2013","unstructured":"Mahevas M, Patin P, Huetz F et al (2013) B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. J Clin Invest 123(1):432\u2013442. https:\/\/doi.org\/10.1172\/JCI65689","journal-title":"J Clin Invest"},{"issue":"1","key":"5348_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12859","volume":"296","author":"Z Hua","year":"2020","unstructured":"Hua Z, Hou B (2020) The role of B cell antigen presentation in the initiation of CD4+ T cell response. Immunol Rev 296(1):24\u201335. https:\/\/doi.org\/10.1111\/imr.12859","journal-title":"Immunol Rev"},{"issue":"11","key":"5348_CR15","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1172\/Jci119822","volume":"100","author":"JL Schultze","year":"1997","unstructured":"Schultze JL, Michalak S, Seamon MJ et al (1997) CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest 100(11):2757\u20132765. https:\/\/doi.org\/10.1172\/Jci119822","journal-title":"J Clin Invest"},{"issue":"12","key":"5348_CR16","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ajh.25632","volume":"94","author":"S Deshayes","year":"2019","unstructured":"Deshayes S, Khellaf M, Zarour A et al (2019) Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: results at 5 years from the French prospective registry ITP-ritux. Am J Hematol 94(12):1314\u20131324. https:\/\/doi.org\/10.1002\/ajh.25632","journal-title":"Am J Hematol"},{"issue":"9","key":"5348_CR17","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1038\/s41418-021-00775-2","volume":"28","author":"L Yang","year":"2021","unstructured":"Yang L, Li N, Yang D et al (2021) CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation. Cell Death Differ 28(9):2616\u20132633. https:\/\/doi.org\/10.1038\/s41418-021-00775-2","journal-title":"Cell Death Differ"},{"issue":"11","key":"5348_CR18","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.1093\/rheumatology\/keab229","volume":"60","author":"S Iwata","year":"2021","unstructured":"Iwata S, Zhang MZ, Hajime M et al (2021) Pathological role of activated mTOR in CXCR3(+) memory B cells of rheumatoid arthritis. Rheumatology 60(11):5452\u20135462. https:\/\/doi.org\/10.1093\/rheumatology\/keab229","journal-title":"Rheumatology"},{"issue":"2","key":"5348_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease (vol 168, pg 960, 2017). Cell 169(2):362\u2013362. https:\/\/doi.org\/10.1016\/j.cell.2017.03.035","journal-title":"Cell"},{"issue":"1","key":"5348_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1128\/Mcb.01187-14","volume":"35","author":"S Benhamron","year":"2015","unstructured":"Benhamron S, Pattanayak SP, Berger M, Tirosh B (2015) mTOR activation promotes plasma cell differentiation and bypasses XBP-1 for immunoglobulin secretion. Mol Cell Biol 35(1):153\u2013166. https:\/\/doi.org\/10.1128\/Mcb.01187-14","journal-title":"Mol Cell Biol"},{"issue":"7","key":"5348_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s13238-011-1077-3","volume":"2","author":"AS Lazorchak","year":"2011","unstructured":"Lazorchak AS, Su B (2011) Perspectives on the role of mTORC2 in B lymphocyte development, immunity and tumorigenesis. Protein Cell 2(7):523\u2013530. https:\/\/doi.org\/10.1007\/s13238-011-1077-3","journal-title":"Protein Cell"},{"issue":"3","key":"5348_CR22","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1111\/jcmm.14089","volume":"23","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Han P, Liu L et al (2019) Indirubin modulates CD4(+) T-cell homeostasis via PD1\/PTEN\/AKT signalling pathway in immune thrombocytopenia. J Cell Mol Med 23(3):1885\u20131898. https:\/\/doi.org\/10.1111\/jcmm.14089","journal-title":"J Cell Mol Med"},{"key":"5348_CR23","doi-asserted-by":"publisher","first-page":"925350","DOI":"10.1155\/2014\/925350","volume":"2014","author":"Y Wang","year":"2014","unstructured":"Wang Y, Zhou YM, Graves DT (2014) FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014:925350. https:\/\/doi.org\/10.1155\/2014\/925350","journal-title":"Biomed Res Int"},{"issue":"1","key":"5348_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/16078454.2022.2151230","volume":"27","author":"D Wang","year":"2022","unstructured":"Wang D, Cassady K, Zou Z, Zhang X, Feng Y (2022) Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia. Hematology 27(1):1282\u20131289. https:\/\/doi.org\/10.1080\/16078454.2022.2151230","journal-title":"Hematology"},{"key":"5348_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmed.2020.00110","volume":"7","author":"Y Feng","year":"2020","unstructured":"Feng Y, Xiao Y, Yan H et al (2020) Sirolimus as rescue therapy for refractory\/relapsed immune thrombocytopenia: results of a single-center, prospective, single-arm study. Front Med (Lausanne) 7:110. https:\/\/doi.org\/10.3389\/fmed.2020.00110","journal-title":"Front Med (Lausanne)"},{"key":"5348_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.exphem.2020.08.001","volume":"89","author":"H Li","year":"2020","unstructured":"Li H, Ji J, Du Y et al (2020) Sirolimus is effective for primary relapsed\/refractory autoimmune cytopenia: a multicenter study. Exp Hematol 89:87\u201395. https:\/\/doi.org\/10.1016\/j.exphem.2020.08.001","journal-title":"Exp Hematol"},{"issue":"11","key":"5348_CR27","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393. https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"issue":"3","key":"5348_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood.2021013393","volume":"139","author":"YJ Wu","year":"2022","unstructured":"Wu YJ, Liu H, Zeng QZ et al (2022) All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP. Blood 139(3):333\u2013342. https:\/\/doi.org\/10.1182\/blood.2021013393","journal-title":"Blood"},{"key":"5348_CR29","doi-asserted-by":"publisher","first-page":"662223","DOI":"10.3389\/fimmu.2021.662223","volume":"12","author":"GE Ringheim","year":"2021","unstructured":"Ringheim GE, Wampole M, Oberoi K (2021) Bruton\u2019s tyrosine kinase (BTK) inhibitors and autoimmune diseases: making sense of BTK inhibitor specificity profiles and recent clinical trial successes and failures. Front Immunol 12:662223. https:\/\/doi.org\/10.3389\/fimmu.2021.662223","journal-title":"Front Immunol"},{"issue":"15","key":"5348_CR30","doi-asserted-by":"publisher","first-page":"19299","DOI":"10.18632\/oncotarget.8244","volume":"7","author":"J Deng","year":"2016","unstructured":"Deng J, Wang X, Chen Q et al (2016) B1a cells play a pathogenic role in the development of autoimmune arthritis. Oncotarget 7(15):19299\u201319311. https:\/\/doi.org\/10.18632\/oncotarget.8244","journal-title":"Oncotarget"},{"key":"5348_CR31","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Wang JY, Kumar V et al (2018) IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun 9:1758. https:\/\/doi.org\/10.1038\/s41467-018-03750-7","journal-title":"Nat Commun"},{"issue":"1","key":"5348_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/imr.12829","volume":"294","author":"M Volkov","year":"2020","unstructured":"Volkov M, van Schie KA, van der Woude D (2020) Autoantibodies and B Cells: the ABC of rheumatoid arthritis pathophysiology. Immunological Reviews 294(1):148\u2013163. https:\/\/doi.org\/10.1111\/imr.12829","journal-title":"Immunological Reviews"},{"issue":"2","key":"5348_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.celrep.2018.06.035","volume":"24","author":"CS Setz","year":"2018","unstructured":"Setz CS, Hug E, Khadour A et al (2018) PI3K-mediated Blimp-1 activation controls B cell selection and homeostasis. Cell Rep 24(2):391\u2013405. https:\/\/doi.org\/10.1016\/j.celrep.2018.06.035","journal-title":"Cell Rep"},{"issue":"1","key":"5348_CR34","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1038\/s41467-020-17798-x","volume":"11","author":"CD Scharer","year":"2020","unstructured":"Scharer CD, Patterson DG, Mi T, Price MJ, Hicks SL, Boss JM (2020) Antibody-secreting cell destiny emerges during the initial stages of B-cell activation. Nat Commun 11(1):3989. https:\/\/doi.org\/10.1038\/s41467-020-17798-x","journal-title":"Nat Commun"},{"issue":"7","key":"5348_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/ni1357","volume":"7","author":"U Klein","year":"2006","unstructured":"Klein U, Casola S, Cattoretti G et al (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7(7):773\u2013782. https:\/\/doi.org\/10.1038\/ni1357","journal-title":"Nat Immunol"},{"issue":"1","key":"5348_CR36","doi-asserted-by":"publisher","first-page":"108211","DOI":"10.1016\/j.celrep.2020.108211","volume":"33","author":"M Syedbasha","year":"2020","unstructured":"Syedbasha M, Bonfiglio F, Linnik J, Stuehler C, Wuthrich D, Egli A (2020) Interferon-lambda enhances the differentiation of naive B cells into plasmablasts via the mTORC1 pathway. Cell Rep 33(1):108211. https:\/\/doi.org\/10.1016\/j.celrep.2020.108211","journal-title":"Cell Rep"},{"key":"5348_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/978-981-15-3266-5_2","volume":"1248","author":"S Van Coillie","year":"2020","unstructured":"Van Coillie S, Wiernicki B, Xu J (2020) Molecular and cellular functions of CTLA-4. Adv Exp Med Biol 1248:7\u201332. https:\/\/doi.org\/10.1007\/978-981-15-3266-5_2","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"5348_CR38","doi-asserted-by":"publisher","first-page":"e45185","DOI":"10.1371\/journal.pone.0045185","volume":"7","author":"TS Lim","year":"2012","unstructured":"Lim TS, Goh JKH, Mortellaro A, Lim CT, Hammerling GJ, Ricciardi-Castagnoli P (2012) CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. Plos One 7(9):e45185. https:\/\/doi.org\/10.1371\/journal.pone.0045185","journal-title":"Plos One"},{"issue":"1","key":"5348_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13075-020-2138-x","volume":"22","author":"PC Liu","year":"2020","unstructured":"Liu PC, Ssu CT, Tsao YP et al (2020) Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells. Arthritis Res Ther 22(1):64. https:\/\/doi.org\/10.1186\/s13075-020-2138-x","journal-title":"Arthritis Res Ther"},{"issue":"7448","key":"5348_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12122","volume":"497","author":"HJ Yang","year":"2013","unstructured":"Yang HJ, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP (2013) mTOR kinase structure, mechanism and regulation. Nature 497(7448):217. https:\/\/doi.org\/10.1038\/nature12122","journal-title":"Nature"},{"key":"5348_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaut.2019.04.016","volume":"101","author":"R Lorenzetti","year":"2019","unstructured":"Lorenzetti R, Janowska I, Smulski CR et al (2019) Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun 101:145\u2013152. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.016","journal-title":"J Autoimmun"},{"issue":"12","key":"5348_CR42","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1074\/jbc.M900301200","volume":"284","author":"CC Thoreen","year":"2009","unstructured":"Thoreen CC, Kang SA, Chang JW et al (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem 284(12):8023\u20138032. https:\/\/doi.org\/10.1074\/jbc.M900301200","journal-title":"J Biol Chem"},{"issue":"6","key":"5348_CR43","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1242\/jcs.146373","volume":"127","author":"J Atkin","year":"2014","unstructured":"Atkin J, Halova L, Ferguson J et al (2014) Torin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cells. J Cell Sci 127(6):1346\u20131356. https:\/\/doi.org\/10.1242\/jcs.146373","journal-title":"J Cell Sci"},{"issue":"6","key":"5348_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/gtc.12366","volume":"21","author":"T Sato","year":"2016","unstructured":"Sato T, Ishii J, Ota Y, Sasaki E, Shibagaki Y, Hattori S (2016) Mammalian target of rapamycin (mTOR) complex 2 regulates filamin A-dependent focal adhesion dynamics and cell migration. Genes Cells 21(6):579\u2013593. https:\/\/doi.org\/10.1111\/gtc.12366","journal-title":"Genes Cells"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05348-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05348-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05348-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:09:58Z","timestamp":1692706198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05348-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["5348"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05348-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in compliance with the Declaration of Helsinki and approved by the Ethics Committee of Qilu Hospital, Shandong University. Informed consent was obtained from all patients for being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}